Wendy J Ungar1, J Michael Paterson, Tara Gomes, Peter Bikangaga, Milton Gold, Teresa To, Anita L Kozyrskyj. 1. Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Health Policy, Management, and Evaluation, University of Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Abstract
BACKGROUND: less than 25% of asthmatic children are well controlled. OBJECTIVE: to identify factors associated with asthma exacerbation causing emergency department (ED) visits or hospitalizations related to health status, socioeconomic status (SES), and drug insurance. METHODS: in this retrospective cohort study, complete data were collected on 490 asthmatic children regarding demographics, SES, drug plan characteristics, health status, health resource use, and symptoms. Interview data were linked to administrative data on asthma ED visits and hospitalizations occurring in the following year. Multiple Poisson regression identified independent variables associated with ED visits or hospitalizations in the full cohort and in a subgroup with prescription drug insurance. RESULTS: younger age, previous emergency visits, nebulizer use, pet ownership, and receipt of asthma education but not an action plan were significantly associated with more frequent exacerbations. In the full cohort, children with high income adequacy had 28% fewer exacerbations than did children with low income adequacy. In the subgroup with drug insurance, girls had 26% fewer exacerbations than did boys, and children with food, drug, or insect allergies had 52% more exacerbations than did children without allergies. Children of families with annual insurance deductibles greater than $90 had 95% fewer exacerbations. Every percentage increase in the proportion of income spent out-of-pocket on asthma medications was associated with a 14% increase in exacerbations. CONCLUSIONS: asthma history, disease management factors, and SES were associated with exacerbations requiring urgent care. In families with drug plans, the magnitude of asthma medication cost-sharing as a proportion of household income, rather than income alone, was significantly associated with exacerbations.
BACKGROUND: less than 25% of asthmatic children are well controlled. OBJECTIVE: to identify factors associated with asthma exacerbation causing emergency department (ED) visits or hospitalizations related to health status, socioeconomic status (SES), and drug insurance. METHODS: in this retrospective cohort study, complete data were collected on 490 asthmatic children regarding demographics, SES, drug plan characteristics, health status, health resource use, and symptoms. Interview data were linked to administrative data on asthma ED visits and hospitalizations occurring in the following year. Multiple Poisson regression identified independent variables associated with ED visits or hospitalizations in the full cohort and in a subgroup with prescription drug insurance. RESULTS: younger age, previous emergency visits, nebulizer use, pet ownership, and receipt of asthma education but not an action plan were significantly associated with more frequent exacerbations. In the full cohort, children with high income adequacy had 28% fewer exacerbations than did children with low income adequacy. In the subgroup with drug insurance, girls had 26% fewer exacerbations than did boys, and children with food, drug, or insect allergies had 52% more exacerbations than did children without allergies. Children of families with annual insurance deductibles greater than $90 had 95% fewer exacerbations. Every percentage increase in the proportion of income spent out-of-pocket on asthma medications was associated with a 14% increase in exacerbations. CONCLUSIONS: asthma history, disease management factors, and SES were associated with exacerbations requiring urgent care. In families with drug plans, the magnitude of asthma medication cost-sharing as a proportion of household income, rather than income alone, was significantly associated with exacerbations.
Authors: Monica J Federico; Frederick S Wamboldt; Rick Carter; Anthony Mansell; Marianne Z Wamboldt Journal: J Allergy Clin Immunol Date: 2006-12-04 Impact factor: 10.793
Authors: Peter G Szilagyi; Andrew W Dick; Jonathan D Klein; Laura P Shone; Jack Zwanziger; Alina Bajorska; H Lorrie Yoos Journal: Pediatrics Date: 2006-02 Impact factor: 7.124
Authors: M Diane Lougheed; Nancy Garvey; Kenneth R Chapman; Lisa Cicutto; Robert Dales; Andrew G Day; Wilma M Hopman; Miu Lam; Malcolm R Sears; Kim Szpiro; Teresa To; Nigel A M Paterson Journal: Chest Date: 2006-04 Impact factor: 9.410
Authors: Tmirah Haselkorn; Robert S Zeiger; Bradley E Chipps; David R Mink; Stanley J Szefler; F Estelle R Simons; Marc Massanari; James E Fish Journal: J Allergy Clin Immunol Date: 2009-11 Impact factor: 10.793
Authors: Dana P Goldman; Geoffrey F Joyce; Jose J Escarce; Jennifer E Pace; Matthew D Solomon; Marianne Laouri; Pamela B Landsman; Steven M Teutsch Journal: JAMA Date: 2004-05-19 Impact factor: 56.272
Authors: Pamela R Wood; Lauren A Smith; Diana Romero; Patrick Bradshaw; Paul H Wise; Wendy Chavkin Journal: Am J Public Health Date: 2002-09 Impact factor: 9.308
Authors: Alison A Galbraith; Vicki Fung; Lingling Li; Melissa G Butler; James D Nordin; John Hsu; David Smith; William M Vollmer; Tracy A Lieu; Stephen B Soumerai; Ann Chen Wu Journal: Health Serv Res Date: 2016-11-20 Impact factor: 3.402
Authors: Christine Loftus; Zahra Afsharinejad; Paul Sampson; Sverre Vedal; Elizabeth Torres; Griselda Arias; Maria Tchong-French; Catherine Karr Journal: Int J Hyg Environ Health Date: 2019-09-19 Impact factor: 5.840
Authors: Chung-Il Wi; Joshua Gauger; Maria Bachman; Jennifer Rand-Weaver; Elizabeth Krusemark; Euijung Ryu; Katherine S King; Slavica K Katusic; Young J Juhn Journal: Ann Epidemiol Date: 2016-05-11 Impact factor: 3.797
Authors: Malinda N Harris; Matthew C Lundien; Dawn M Finnie; Arthur R Williams; Timothy J Beebe; Jeffrey A Sloan; Barbara P Yawn; Young J Juhn Journal: NPJ Prim Care Respir Med Date: 2014-06-26 Impact factor: 2.871